November 2020 • PharmaTimes Magazine • 4-5


Contents


Features

How pharma’s commitment to logistics has provided a supersonic slipstream to optimal performance


Lessons from the Patient Partnership Index conference


Revolutionising clinical trials with wearables and digital endpoints


Analysis

Why pharma needs to put data at the heart of its bid to support the NHS Reset


The question of artificial intelligence as an inventor – and what it means for drug discovery


What companies must do to maintain continuity of supply once the Brexit transition period ends


How pharma companies have improved how they engage with healthcare providers during COVID-19


Insight into the conduct of clinical trials and managing data amid the pandemic


SmartPeople

Cheryl Yoder shares her family’s experiences with this rare, genetic disorder



Professor Sir Leszek Borysiewicz, chairman of Cancer Research UK, on the need for greater focus on cancer diagnosis